Bourret JA - Search Results

1

Overview of alopecia areata for managed care and payer stakeholders in the United States.

King B, Pezalla E, Fung S, Tran H, Bourret JA, Peeples-Lamirande K, Takiya L, Napatalung L. King B, et al. Among authors: bourret ja. J Manag Care Spec Pharm. 2023 Jul;29(7):848-856. doi: 10.18553/jmcp.2023.22371. Epub 2023 May 23. J Manag Care Spec Pharm. 2023. PMID: 37219075 Free PMC article.

2

Delayed Treatment Acceleration in Patients with Rheumatoid Arthritis Who Have Inadequate Response to Initial Tumor Necrosis Factor Inhibitors: Data from the Corrona Registry.

Pappas DA, Gerber RA, Litman HJ, Gruben D, Geier J, Hua WD, Chen C, Li Y, Kremer JM, Andrews JS, Bourret JA. Pappas DA, et al. Among authors: bourret ja. Am Health Drug Benefits. 2018 May;11(3):148-158. Am Health Drug Benefits. 2018. PMID: 29910846 Free PMC article.

3

An Economic Evaluation of Tofacitinib Treatment in Rheumatoid Arthritis After Methotrexate or After 1 or 2 TNF Inhibitors from a U.S. Payer Perspective.

Claxton L, Taylor M, Soonasra A, Bourret JA, Gerber RA. Claxton L, et al. Among authors: bourret ja. J Manag Care Spec Pharm. 2018 Oct;24(10):1010-1017. doi: 10.18553/jmcp.2018.17220. Epub 2018 Jun 13. J Manag Care Spec Pharm. 2018. PMID: 29897007 Free PMC article.

4

The Challenge of Managing Psoriasis: Unmet Medical Needs and Stakeholder Perspectives.

Feldman SR, Goffe B, Rice G, Mitchell M, Kaur M, Robertson D, Sierka D, Bourret JA, Evans TS, Gottlieb A. Feldman SR, et al. Among authors: bourret ja. Am Health Drug Benefits. 2016 Dec;9(9):504-513. Am Health Drug Benefits. 2016. PMID: 28465778 Free PMC article. Review.

5

An Economic Evaluation of Tofacitinib Treatment in Rheumatoid Arthritis: Modeling the Cost of Treatment Strategies in the United States.

Claxton L, Jenks M, Taylor M, Wallenstein G, Mendelsohn AM, Bourret JA, Singh A, Moynagh D, Gerber RA. Claxton L, et al. Among authors: bourret ja. J Manag Care Spec Pharm. 2016 Sep;22(9):1088-102. doi: 10.18553/jmcp.2016.22.9.1088. J Manag Care Spec Pharm. 2016. PMID: 27579831 Free PMC article.

6

Medication use review process and information systems utilized for oncology chemotherapy quality improvement.

Bourret JA, Demers RF, Wordell D, Irani M, Baker J, Evangelista C. Bourret JA, et al. Pharm Pract Manag Q. 1996 Apr;16(1):1-17. Pharm Pract Manag Q. 1996. PMID: 10157736

7

Job characteristics and satisfaction of pharmacy technicians.

Cortese LM, Greenberger DW, Schneider PJ, Bourret JA. Cortese LM, et al. Among authors: bourret ja. Am J Hosp Pharm. 1987 Nov;44(11):2514-8. Am J Hosp Pharm. 1987. PMID: 3687990

8

Costs of training drug-administration technicians.

Fillmore AD, Schneider PJ, Bourret JA, Caswell RJ. Fillmore AD, et al. Among authors: bourret ja. Am J Hosp Pharm. 1986 Jul;43(7):1706-9. Am J Hosp Pharm. 1986. PMID: 3752105

9

Activity analysis of pharmacy-directed drug-administration technicians.

Scala SM, Schneider PJ, Smith GL Jr, Bourret JA. Scala SM, et al. Among authors: bourret ja. Am J Hosp Pharm. 1986 Jul;43(7):1702-6. Am J Hosp Pharm. 1986. PMID: 3752104

10

Cost justifying a pharmacy residency program.

Schneider PJ, Boman DM, Bourret JA, Ngu BQ, Ouellette SM, Smeek DM. Schneider PJ, et al. Among authors: bourret ja. Am J Hosp Pharm. 1982 Sep;39(9):1517-20. Am J Hosp Pharm. 1982. PMID: 6814246

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters